PH21837A - Treatment of vernal conjunctivitis - Google Patents

Treatment of vernal conjunctivitis

Info

Publication number
PH21837A
PH21837A PH31955A PH31955A PH21837A PH 21837 A PH21837 A PH 21837A PH 31955 A PH31955 A PH 31955A PH 31955 A PH31955 A PH 31955A PH 21837 A PH21837 A PH 21837A
Authority
PH
Philippines
Prior art keywords
treatment
vernal conjunctivitis
vernal
conjunctivitis
polyvalent
Prior art date
Application number
PH31955A
Other languages
English (en)
Inventor
Alfred Hassig
Urs Ernst Nydegger
Original Assignee
Schweiz Rotes Kreuz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schweiz Rotes Kreuz filed Critical Schweiz Rotes Kreuz
Publication of PH21837A publication Critical patent/PH21837A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH31955A 1984-03-13 1985-03-07 Treatment of vernal conjunctivitis PH21837A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848406560A GB8406560D0 (en) 1984-03-13 1984-03-13 Organic compounds

Publications (1)

Publication Number Publication Date
PH21837A true PH21837A (en) 1988-03-17

Family

ID=10558020

Family Applications (1)

Application Number Title Priority Date Filing Date
PH31955A PH21837A (en) 1984-03-13 1985-03-07 Treatment of vernal conjunctivitis

Country Status (9)

Country Link
US (1) US4721616A (de)
EP (1) EP0155235B1 (de)
JP (1) JPS60252428A (de)
AT (1) ATE32660T1 (de)
AU (1) AU577840B2 (de)
DE (2) DE3561685D1 (de)
GB (1) GB8406560D0 (de)
IT (1) IT1208508B (de)
PH (1) PH21837A (de)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903262A (en) * 1972-03-13 1975-09-02 Cutter Lab Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use
FR2222083B1 (de) * 1973-03-22 1976-05-14 Fontaine Michel
BE812801A (fr) * 1973-03-26 1974-07-15 Procede d'immunoregulation
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
DE2856939A1 (de) * 1978-12-13 1980-07-03 Schura Blutderivate Gmbh & Co Verfahren zur gewinnung von intravenoes-vertraeglichen gammaglobulinen
JPS57206608A (en) * 1981-05-29 1982-12-18 Mochida Pharmaceut Co Ltd Production of gamma-globulin for intravenous injection
BE897227A (fr) * 1982-07-13 1984-01-06 Sandoz Sa Traitement des troubles allergiques
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
DE3340487A1 (de) * 1983-11-09 1985-05-15 Sandoz-Patent-GmbH, 7850 Lörrach Neue therapeutische verwendung

Also Published As

Publication number Publication date
EP0155235A3 (en) 1986-11-05
EP0155235A2 (de) 1985-09-18
AU577840B2 (en) 1988-10-06
US4721616A (en) 1988-01-26
IT8519855A0 (it) 1985-03-12
JPS60252428A (ja) 1985-12-13
DE3561685D1 (en) 1988-04-07
IT1208508B (it) 1989-07-10
DE3508750A1 (de) 1985-09-19
EP0155235B1 (de) 1988-03-02
GB8406560D0 (en) 1984-04-18
AU3975385A (en) 1985-09-19
ATE32660T1 (de) 1988-03-15

Similar Documents

Publication Publication Date Title
ES515177A0 (es) Procedimiento para el tratamiento de inmunoglobulina de suero.
ATE50269T1 (de) Kontrolliertes crackverfahren von alphaolefinpolymerisaten.
OA06811A (fr) Procédé de préparation de nouveaux dérivés de pyridoxine.
EP0413188A3 (en) Unmodified intravenous igm- and/or iga-containing immunoglobulin preparation and process therefor
EP0246579A3 (en) Method of producing immunoglobulin preparations for intravenous injection
HUT54214A (en) Process for reducing immunoglobulin e response
NO852985L (no) Fremgangsmaate for drift av et aktivert slamsystem
GR3003933T3 (de)
DK158496C (da) Middel til behandling af saar
ES8705230A1 (es) Procedimiento para preparar gamma-globulinas administrables por via intravenosa
DE3561685D1 (en) Treatment of vernal conjunctivitis
DZ687A1 (fr) Dérivés de la chlori-4-furo-(3,4-c)-pyridine et leur procédé de préparation.
DK179981A (da) Fremgangsmaade til fremstilling af deazepurinnucleosider
AU6089086A (en) Treatment of chronic inflammatory disease
DE3070871D1 (en) Direct on-column injector and injection method
NO161274C (no) Fremgangsm te for fremstilling av immuninterferon.
SE8107750L (sv) Frekvensbegrensad hjertstimulator
EP0252053A3 (de) Verfahren zur Kontrole chemischer Reaktivität und hergestellte Produkte
SE8103939L (sv) Indolo(2';3,4)pyrido(2,1-b)kinazolin-5-oner jemte sett for deras framstellning
GR862785B (en) Method of controlled combustion by ionization
SU1396333A1 (ru) Способ приготовления катализатора для крекинга нефтяных фракций
IT8419911A0 (it) Procedimento per desolforare olii combustibili.
FI880080A (fi) Foerfarande foer framstaellning av 1,2,3,4-tetrahydro-5h-(1)bensopyrano-(3,4-c)pyridin-5-on.